Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: the first decade.

A Mountain1

  • 1Cobra Therapeutics, The Science Park, University of Keele, Keele, Staffordshire, UK ST5 5SP. andy.mountain@cobrat.com

Trends in Biotechnology
|February 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivering high-quality military healthcare: 'no need for fancy subspecialties'.

BMJ military health·2024
Same author

Secure app-based secondary healthcare clinical decision support to deployed forces in the UK Defence Medical Services.

BMJ military health·2022
Same author

Battlefield REBOA: Aces High or Journey's End?

BMJ military health·2022
Same author

Outcomes following limb salvage after combat hindfoot injury are inferior to delayed amputation at five years.

Bone & joint research·2018
Same author

A retrospective study into the levels of evidence presented at the Combined Services Orthopaedic Society annual meeting.

Journal of the Royal Army Medical Corps·2011
Same author

Management of a complex hind foot war injury with negative pressure wound therapy: a case study.

Foot (Edinburgh, Scotland)·2010
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Gene therapy is revolutionizing medicine by treating disease causes. Recent advances in gene-transfer vectors show clear clinical benefits, fulfilling gene therapy's potential.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Medical Science

Background:

  • Gene therapy offers a revolutionary approach to treating diseases at their root cause, rather than just managing symptoms.
  • The first decade of gene therapy research has provided valuable insights into its potential and challenges.

Purpose of the Study:

  • To summarize the progress, achievements, and lessons learned in gene therapy over its initial decade.
  • To highlight recent developments and the future prospects of gene therapy.

Main Methods:

  • Review of gene therapy approaches employed.
  • Analysis of achieved clinical efficacy results.
  • Evaluation of gene-transfer vector development and selection.

Main Results:

Related Experiment Videos

  • Early gene therapy trials showed disappointing clinical efficacy due to inadequate gene-transfer vectors.
  • Recent advancements have led to clearly demonstrated clinical benefits.
  • Significant progress has been made in improving and selecting suitable vectors for gene therapy.

Conclusions:

  • Gene therapy is transitioning from a promising concept to a clinically effective treatment modality.
  • The ongoing improvements in vector technology suggest gene therapy will realize its full potential in the coming decade.